So for those who are paying attention today's PR i

So for those who are paying attention today's PR is yet another example of 1) the company hitting the endpoint targets set in their trials, which is great news, but more importantly 2) another public statement which tells us that Kevitrin is working in the real application. IPIX knows that K work on human cell cancer lines and in mice in the lab. They have seen cancer reduce or be eliminated. They cant tell us yet that it works because they dont know all of the 'how' that it works. Plus they can never say with certainty that it does until they gather the hard data from the trials to demonstrate efficacy. But Menon and company have been in the drug development business long enough to know when they have something which is going to work. My OPINION is that all these trials are only to make sure it is non-toxic (already done) and to understand how well K works. That will allow them to optimize it for fighting cancer, NOT to see IF it works or not.

P.S. (Yes I also do understand the the trials are a requirement for FDA approvals and getting the drug to market, but I think you get my point.)